IQV
IQVXNYS

IQVIA Holdings Inc.

Market cap $34.7B

$208.05

+10.29 (+5.20%)past year

IQV

$208.05

+0.35% today

Market price$208.05
Shares1
Est. total$208.05

Buy with €1M virtual cash · No real money

IQVIA Holdings Inc. (IQV) is a publicly traded company listed on the XNYS. As of July 27, 2026, Invest's signal rates IQV a Buy, with the stock up 7% over the past year. You can practice trading IQV risk-free with €1,000,000 in virtual cash.

Key stats

As of July 27, 2026

Market Cap

$34.7B

Volume

1.1M

52-wk High

$247.05

52-wk Low

$154.50

Day High

$209.99

Day Low

$206.92

P/E (TTM)

25.81

Revenue (TTM)

$16.6B

EPS (TTM)

$8.06

Performance

1M

+12.1%

6M

-13.0%

1Y

+7.1%

Invest signal · IQV

Buy
SellHoldBuy
1-year trend+7%
3-month momentum+29%
Valuation (P/E)25.8
Revenue growth (QoQ)-4.9%
Profitability (EPS)Profitable

Algorithmic signal from price trend, valuation, and fundamentals — educational only, not financial advice.

IQV overview

AI overview

Revenue & EPS — last 8 quarters

QoQ rev -4.9%

Revenue

$4B
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Q1 '26

EPS (diluted)

$1.61 per share
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Q1 '26

About IQVIA Holdings Inc.

Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process.

Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.

Employees

93,000

www.iqvia.com

30-Day Win Rate · IQV

57%WIN RATE
Up days

13 days

Down days

10 days

Last 23 sessions

How to practice trading IQV

  1. 1

    Use the IQV buy panel above

    Set a quantity and hit Buy at the real market price — right here, nothing to download.

  2. 2

    Trade with €1,000,000 virtual cash

    You get a million in virtual money instantly to invest, risk-free.

  3. 3

    Create a free account to save it

    Sign up in seconds to keep your portfolio and track its performance.

  4. 4

    Track and compete

    Watch your portfolio grow and climb the global leaderboard — or start a private league.

  5. 5

    Prefer mobile? Get the iOS app

    Invest is also free on the App Store, synced with your web account.

Top IQV traders on Invest

Full leaderboard
🥇isabela_g+93.0%
🥈Chloe N.+82.0%
🥉Ava Martin+70.0%
#4sophie.l+61.0%
#5Emma R.+49.0%

Frequently asked questions

Is IQV a good stock to buy right now?

As of July 27, 2026, Invest's signal rates IQV a Buy, based on its price trend, valuation, and fundamentals (P/E around 25.8), with the stock up 7% over the past year. This is an educational signal, not financial advice — the best way to test the thesis is to practice trading IQV risk-free first.

What is IQVIA Holdings Inc.'s (IQV) market cap?

IQVIA Holdings Inc. has a market capitalization of approximately $34.7B, on trailing-twelve-month revenue of about $16.6B.

How has IQV stock performed?

IQV is up 7% over the past year and down 13% over six months. Its 52-week range runs roughly from $154.50 to $247.05. Past performance doesn't predict future results.

How can I practice trading IQV for free?

On Invest you get €1,000,000 in virtual cash and can buy IQV at real market prices right in your browser — no download and no real money at risk. Create a free account to save your portfolio and track its performance over time.

More stocks to practice

Compare IQV with peers

Invest — Stock Market SimulatorNot financial advice.